Oncotarget - Hyperprogression To Immune Blockade Followed By A Response With Cabozantinib by Oncotarget Podcast

Oncotarget - Hyperprogression To Immune Blockade Followed By A Response With Cabozantinib

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed.

Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/

Science

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed. Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed. Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/

Share Oncotarget - Hyperprogression To Immune Blockade Followed By A Response With Cabozantinib

Sign up to save your podcasts

Oncotarget - Hyperprogression To Immune Blockade Followed By A Response With Cabozantinib

Oncotarget - Hyperprogression To Immune Blockade Followed By A Response With Cabozantinib